Eberle C, Stichling S. Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review. Diabetol Metab Syndr. 2021;13:95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han Y, Chen Y, Sun C, Zhou Z. The impact of COVID lockdown on glycaemic control in paediatric patients with type 1 diabetes: a systematic review and meta-analysis of 22 observational studies. Front Endocrinol. 2022;13:1069559.

Article  Google Scholar 

Wafa IA, Pratama NR, Sofia NF, Anastasia ES, Konstantin T, Wijaya MA, et al. Impact of COVID-19 lockdown on the metabolic control parameters in patients with diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab J. 2022;46:260–72.

Article  PubMed  PubMed Central  Google Scholar 

Ojo O, Wang XH, Ojo OO, Orjih E, Pavithran N, Adegboye ARA, et al. The effects of COVID-19 lockdown on glycaemic control and lipid profile in patients with type 2 diabetes: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19:1095.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Endo K, Miki T, Itoh T, Kubo H, Ito R, Ohno K, et al. Impact of the COVID-19 pandemic on glycemic control and blood pressure control in patients with diabetes in Japan. Intern Med. 2022;61:37–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Munekawa C, Hosomi Y, Hashimoto Y, Okamura T, Takahashi F, Kawano R, et al. Effect of coronavirus disease 2019 pandemic on the lifestyle and glycemic control in patients with type 2 diabetes: a cross-section and retrospective cohort study. Endocr J. 2021;68:201–10.

Article  CAS  PubMed  Google Scholar 

Takahara M, Watanabe H, Shiraiwa T, Maeno Y, Yamamoto K, Shiraiwa Y, et al. Lifestyle changes and their impact on glycemic control and weight control in patients with diabetes during the coronavirus disease 2019 pandemic in Japan. J Diabetes Investig. 2022;13:375–85.

Article  CAS  PubMed  Google Scholar 

Takebayashi K, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K. Seasonal variations and the influence of COVID-19 pandemic on hemoglobin A1c, glycoalbumin, and low-density lipoprotein cholesterol. Diabetol Int. 2022;13:599–605.

Article  PubMed  PubMed Central  Google Scholar 

Park SD, Kim SW, Moon JS, Lee YY, Cho NH, Lee JH, et al. Impact of social distancing due to coronavirus disease 2019 on the changes in glycosylated hemoglobin level in people with type 2 diabetes mellitus. Diabetes Metab J. 2021;45:109–14.

Article  PubMed  Google Scholar 

Uno-Eder K, Satoh-Asahara N, Hibiya M, Uno K, Uchino T, Morita K, et al. Understanding impacts of COVID-19 restrictions on glycemic control for patients with diabetes in Japan. J Diabetes Metab Disord. 2023;22:1695–703.

Article  CAS  PubMed  Google Scholar 

Sankar P, Ahmed WN, Mariam Koshy V, Jacob R, Sasidharan S. Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: a hospital-based cross-sectional survey from South India. Diabetes Metab Syndr. 2020;14:1815–9.

Article  PubMed  PubMed Central  Google Scholar 

Satoh M, Murakami T, Obara T, Metoki H. Time-series analysis of blood pressure changes after the guideline update in 2019 and the coronavirus disease pandemic in 2020 using Japanese longitudinal data. Hypertens Res. 2022;45:1408–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ito S, Kobayashi K, Chin K, Umezawa S, Yamamoto H, Nakano S, et al. Impact of the first announced state of emergency owing to coronavirus disease 2019 on stress and blood pressure levels among patients with type 2 diabetes mellitus in Japan. J Diabetes Investig. 2022;13:1607–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gotanda H, Liyanage-Don N, Moran AE, Krousel-Wood M, Green JB, Zhang Y, et al. Changes in blood pressure outcomes among hypertensive individuals during the COVID-19 pandemic: a time series analysis in three US healthcare organizations. Hypertension. 2022;79:2733–42.

Article  CAS  PubMed  Google Scholar 

Hu Z, Youn HM, Quan J, Lee LLS, Mak IL, Yu EYT, et al. The indirect impact of the COVID-19 pandemic on people with type 2 diabetes mellitus and without COVID-19 infection: systematic review and meta-analysis. Prim Care Diabetes. 2023;17:229–37.

Article  PubMed  PubMed Central  Google Scholar 

Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, J-DOIT3 Study Group, et al. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2017;5:951–64.

Article  PubMed  Google Scholar 

Kannan S, Mahadevan S, Ramji B, Jayapaul M, Kumaravel V. LDL-cholesterol: Friedewald calculated versus direct measurement-study from a large Indian laboratory database. Indian J Endocrinol Metab. 2014;18:502–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, et al. Japanese Clinical Practice Guideline for Diabetes 2019. Diabetol Int. 2020;11:165–223.

Article  PubMed  PubMed Central  Google Scholar 

Sakamoto M, Matsutani D, Minato S, Tsujimoto Y, Kayama Y, Takeda N, et al. Seasonal Variations in the Achievement of Guideline Targets for HbA1c, blood pressure, and cholesterol among patients with type 2 diabetes: a nationwide population-based study (ABC study: JDDM49). Diabetes Care. 2019;42:816–23.

Article  CAS  PubMed  Google Scholar 

Zhu L, She ZG, Cheng X, Qin JJ, Zhang XJ, Cai J, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31:1068–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17:11–30.

Article  CAS  PubMed  Google Scholar 

Wu CT, Lidsky PV, Xiao Y, Lee IT, Cheng R, Nakayama T, et al. SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment. Cell Metab. 2021;33:1565–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yokoyama H, Oishi M, Takamura H, Yamasaki K, Shirabe SI, Uchida D, et al. Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40). BMJ Open Diabetes Res Care. 2016;4:e000294.

Article  PubMed  PubMed Central  Google Scholar 

Shirabe S, Yamazaki K, Oishi M, Arai K, Yagi N, Sato M, et al. Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type 2 diabetes (JDDM70). J Diabetes Investig. 2023;14:75–80.

Article  CAS  PubMed  Google Scholar 

Iketani R, Imai S. Prescription trends for the antidiabetic agents used to treat Type 2 diabetes mellitus in Japan from 2012–2020: a time-series analysis. Biol Pharm Bull. 2023;46:592–8.

Article  CAS  PubMed  Google Scholar 

Zhang S, Zhong Y, Wang L, Yin X, Li Y, Liu Y, STEP Study Group, et al. Anxiety, home blood pressure monitoring, and cardiovascular events among older hypertension patients during the COVID-19 pandemic. Hypertens Res. 2022;45:856–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Celik M, Yilmaz Y, Karagoz A, Kahyaoglu M, Cakmak EO, Kup A, et al. Anxiety disorder associated with the COVID-19 pandemic causes deterioration of blood pressure control in primary hypertensive patients. Medeni Med J. 2021;36:83–90.

PubMed  PubMed Central  Google Scholar 

Morgan R, Baker P, Griffith DM, Klein SL, Logie CH, Mwiine AA, et al. Beyond a zero-sum game: how does the impact of COVID-19 vary by gender? Front Sociol. 2021;6:650729.

Article  PubMed  PubMed Central  Google Scholar 

Wenham C, Smith J, Davies SE, Feng H, Grépin KA, Harman S, et al. Women are most affected by pandemics—lessons from past outbreaks. Nature. 2020;583:194–8.

Article  CAS  PubMed  Google Scholar 

Park SH, Shin JH, Park J, Choi WS. An updated meta-analysis of remote blood pressure monitoring in urban-dwelling patients with hypertension. Int J Environ Res Public Health. 2021;18:10583.

Article  CAS  PubMed  PubMed Central  Google Scholar 

D’Onofrio L, Pieralice S, Maddaloni E, Mignogna C, Sterpetti S, Coraggio L, et al. Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study. Diabetes Obes Metab. 2021;23:1624–30.

Article  PubMed  PubMed Central  Google Scholar 

Karatas S, Yesim T, Beysel S. Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people. Prim Care Diabetes. 2021;15:424–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Selek A, Gezer E, Altun E, Sözen M, Topaloğlu Ö, Köksalan D, et al. The impact of COVID-19 pandemic on glycemic control in patients with diabetes mellitus in Turkey: a multi-center study from Kocaeli. J Diabetes Metab Disord. 2021;20:1461–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin CW, Hung SY, Chen IW. A study of glycemic perturbations following two doses of COVID-19 vaccination for patients with diabetes: the impacts of vaccine type and